Back to Search
JENNIFER SIEGFRIED, PHARMD
PHARMD
Pharmacist
NPI: 1831426014Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
20623(NC)
Research & Publications (20)
Elevated hepatocyte growth factor level correlates with poor outcome in early-stage and late-stage adenocarcinoma of the lung.
PMID 15136456·Chest·2004
8-other
HGF and c-Met participate in paracrine tumorigenic pathways in head and neck squamous cell cancer.
PMID 19470725·Clin Cancer Res·2009
7-preclinical
Prospective study of breast MRI in BRCA1 and BRCA2 mutation carriers: effect of mutation status on cancer incidence.
PMID 19609668·Breast Cancer Res Treat·2009
3-trial
Pilot study of gefitinib and fulvestrant in the treatment of post-menopausal women with advanced non-small cell lung cancer.
PMID 18701186·Lung Cancer·2009
8-other
Fibulin-5 suppresses lung cancer invasion by inhibiting matrix metalloproteinase-7 expression.
PMID 19584278·Cancer Res·2009
7-preclinical
Estrogen receptor beta (ERbeta) subtype-specific ligands increase transcription, p44/p42 mitogen activated protein kinase (MAPK) activation and growth in human non-small cell lung cancer cells.
PMID 19460433·J Steroid Biochem Mol Biol·2009
8-other
Association of radiographic emphysema and airflow obstruction with lung cancer.
PMID 18565949·Am J Respir Crit Care Med·2008
8-other
Combined inhibition of c-Src and epidermal growth factor receptor abrogates growth and invasion of head and neck squamous cell carcinoma.
PMID 18594011·Clin Cancer Res·2008
8-other
The Pittsburgh Lung Screening Study (PLuSS): outcomes within 3 years of a first computed tomography scan.
PMID 18635890·Am J Respir Crit Care Med·2008
8-other
Therapeutic targeting of human hepatocyte growth factor with a single neutralizing monoclonal antibody reduces lung tumorigenesis.
PMID 18645002·Mol Cancer Ther·2008
7-preclinical
Kinin b2 receptor mediates induction of cyclooxygenase-2 and is overexpressed in head and neck squamous cell carcinomas.
PMID 19074839·Mol Cancer Res·2008
8-other
Downregulation of Dkk3 activates beta-catenin/TCF-4 signaling in lung cancer.
PMID 18048388·Carcinogenesis·2008
8-other
Immunohistochemical analysis of phosphotyrosine signal transducer and activator of transcription 3 and epidermal growth factor receptor autocrine signaling pathways in head and neck cancers and metastatic lymph nodes.
PMID 18316548·Clin Cancer Res·2008
8-other
The relative contribution of point mutations and genomic rearrangements in BRCA1 and BRCA2 in high-risk breast cancer families.
PMID 18703817·Cancer Res·2008
8-other
Multiple cytokine and growth factor serum biomarkers predict therapeutic response and survival in advanced-stage head and neck cancer patients.
PMID 17545511·Clin Cancer Res·2007
8-other
Signaling pathways involved in cyclooxygenase-2 induction by hepatocyte growth factor in non small-cell lung cancer.
PMID 17550984·Mol Pharmacol·2007
4-observational
Frequent inactivation of RAMP2, EFEMP1 and Dutt1 in lung cancer by promoter hypermethylation.
PMID 17671114·Clin Cancer Res·2007
2-rct
Diagnostic accuracy of MALDI mass spectrometric analysis of unfractionated serum in lung cancer.
PMID 17909350·J Thorac Oncol·2007
4-observational
Promoter methylation of RASSF1A and DAPK and mutations of K-ras, p53, and EGFR in lung tumors from smokers and never-smokers.
PMID 17477876·BMC Cancer·2007
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3703 LAWNDALE DR
GREENSBORO, NC 27455 - Phone
- (336) 540-1344
Quick Facts
- NPI
- 1831426014
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile